The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Short Bowel Syndrome Market Expected To Change Between 2026 And 2030?
The market size for short bowel syndrome has experienced rapid expansion in recent years. It is projected to increase from $3.08 billion in 2025 to $3.53 billion by 2026, showing a compound annual growth rate (CAGR) of 14.6%. The expansion observed in the historic period can be attributed to factors such as the increasing prevalence of short bowel syndrome, historically limited treatment options, a reliance on parenteral nutrition, a rise in gastrointestinal surgeries, and growing awareness within hospitals.
The short bowel syndrome market size is anticipated to experience substantial growth over the coming years, with projections indicating it will reach $6.02 billion by 2030, expanding at a compound annual growth rate (CAGR) of 14.2%. This expected increase during the forecast period is primarily driven by the introduction of novel therapeutics, improved access to home infusion services, the emergence of personalized treatment approaches, the integration of microbiome therapies, and a rise in clinical trials for SBS interventions. Significant trends identified for this period encompass an increase in parenteral nutrition solutions, the ongoing development of intestinal rehabilitation therapies, the adoption of innovative surgical interventions, a heightened focus on gut microbiome modulation, and the expansion of patient support programs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23515&type=smp
What Underlying Factors Are Accelerating The Growth Of The Short Bowel Syndrome Market?
The rising incidence of gastrointestinal ailments is anticipated to drive expansion within the short bowel syndrome market in the future. Gastrointestinal diseases encompass a broad spectrum of conditions impacting the digestive tract, including disorders affecting the stomach, intestines, liver, and pancreas, frequently leading to impaired digestion and nutrient absorption. The increasing occurrence of these diseases is largely fueled by unhealthy dietary habits that disrupt gut health and foster inflammation. Gastrointestinal conditions can contribute to the development of short bowel syndrome by necessitating the surgical removal of damaged intestinal segments, resulting in reduced absorptive capacity. For example, in September 2023, information from the Inflammatory Bowel Disease (IBD) Clinical and Research Centre, a Canada-based organization focused on enhancing the lives of patients with Crohn’s disease and ulcerative colitis, indicated that over 320,000 people in Canada suffer from inflammatory bowel disease (IBD), with a prevalence of 825 per 100,000 in 2023. As the prevalence is expected to increase by 2.44% annually, projections suggest that 1.1% of the population, or 470,000 Canadians, will be living with IBD by 2035. Therefore, the growing prevalence of gastrointestinal diseases is stimulating the growth of the short bowel syndrome market.
How Is The Short Bowel Syndrome Market Structured Across Different Segments?
The short bowel syndrome market covered in this report is segmented –
1) By Type: Glucagon-Like Peptide (GLP-2), Growth Hormone, Glutamine
2) By Diagnosis: Physical Exam, Blood Tests, Fecal Fat Tests, Imaging Procedures, Other Diagnosis
3) By Treatment: Nutritional Therapy, Medications, Surgery, Transplant
4) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Other Distribution Channels
Subsegments:
1) By Glucagon-Like Peptide (GLP-2): Teduglutide, Other GLP-2 Analogues
2) By Growth Hormone: Somatropin, Other Growth Hormone Therapies
3) By Glutamine: Oral Glutamine, Intravenous Glutamine
What Major Market Trends Are Driving Changes In The Short Bowel Syndrome Market?
Companies active in the short bowel syndrome market are concentrating on creating pioneering advancements in medical science, such as therapies for intestinal failure, to deliver an enhanced therapeutic choice that improves patient outcomes for those with gastrointestinal disorders. Intestinal failure is a severe condition where the small intestine cannot adequately absorb enough nutrients, fluids, and electrolytes essential for maintaining proper hydration and nutrition. For instance, in May 2024, Ironwood Pharmaceuticals, Inc., a US-based healthcare company, disclosed new data from studies evaluating apraglutide in adults with short bowel syndrome and intestinal failure (SBS-IF). As a next-generation GLP-2 analog, apraglutide exhibited potential to augment intestinal absorption and lessen the dependence on parenteral support. The findings emphasize the drug’s efficacy, safety, and long-term benefits, reflecting Ironwood’s commitment to advancing innovative therapies for gastrointestinal disorders.
Which Major Players Dominate The Short Bowel Syndrome Market?
Major companies operating in the short bowel syndrome market are Nestlé SA, Pfizer Inc, Johnson & Johnson, Sanofi SA, Nutrinia, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Zealand Pharma, Baxter International Inc., OPKO Health Inc, Ironwood Pharmaceuticals Inc., Hanmi Pharm Co Ltd, Emmaus Life Sciences Inc, Jaguar Health, 9 Meters Biopharma Inc, OxThera Inc, EnteraBio Ltd, GLyPharma Therapeutic Inc, Fresenius Kabi AG, Danone S A, B Braun Melsungen AG, Medtronic plc
Read the full short bowel syndrome market report here:
https://www.thebusinessresearchcompany.com/report/short-bowel-syndrome-global-market-report
Which Region Is Projected To Dominate The Short Bowel Syndrome Market During The Forecast Period?
North America was the largest region in the short bowel syndrome market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short bowel syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Short Bowel Syndrome Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=23515&type=smp
Browse Through More Reports Similar to the Global Short Bowel Syndrome Market 2026, By The Business Research Company
Bowel Management Systems Global Market Report
https://www.thebusinessresearchcompany.com/report/bowel-management-systems-global-market-report
Inflammatory Bowel Disease Treatment Global Market Report
Ulcerative Colitis Global Market Report
https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model